VANCOUVER, Oct. 25 /CNW/ - Protox Therapeutics Inc. (TSX-V:PRX) (“Protox”) announced today that it intends to raise $8 million to $10 million (CDN) through a private placement of Units at $0.50 per Unit. The private placement will be sold through Jennings Capital Inc. and Canaccord Capital Corporation as agents.
